Study to Evaluate SC Route of Administration of Ofatumumab in RA Patients
Status:
Completed
Trial end date:
2011-05-02
Target enrollment:
Participant gender:
Summary
This study will examine the safety and tolerability, PK and PD of subcutaneously administered
GSK1841157 in patients with RA on stable dose Methotrexate. The study comprises a single dose
escalation/de-escalation phase to investigate the minimal efficacious dose based on PD
markers with an acceptable safety profile.